AAAAAA

   
Results: 1-19 |
Results: 19
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study
Authors: Lepri, AC Phillips, AN Monforte, AD Castelli, F Antinori, A de Luca, A Pezzotti, P Alberici, F Cargnel, A Grima, P Piscopo, R Prestileo, T Scalise, G Vigevani, M Moroni, M
Citation: Ac. Lepri et al., When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study, AIDS, 15(8), 2001, pp. 983-990
Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre
Authors: Mocroft, A Youle, M Moore, A Sabin, CA Madge, S Lepri, AC Tyrer, M Chaloner, C Wilson, D Loveday, C Johnson, MA Phillips, AN
Citation: A. Mocroft et al., Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre, AIDS, 15(2), 2001, pp. 185-194
The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4-8 viral load
Authors: Lepri, AC Miller, V Phillips, AN Rabenau, H Sabin, CA Staszewski, S
Citation: Ac. Lepri et al., The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4-8 viral load, AIDS, 15(1), 2001, pp. 47-54
Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia
Authors: Sabin, CA Lepri, AC Devereux, H Phillips, AN Loveday, C Lee, CA
Citation: Ca. Sabin et al., Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia, J INFEC DIS, 184(4), 2001, pp. 511-514
Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection
Authors: Rezza, G Lepri, AC Monforte, AD Pezzotti, P Castelli, F Dianzani, F Lazzarin, A De Luca, A Arlotti, M Leoncini, F Manconi, PE Rizzardini, G Minoli, L Poggio, A Ippolito, G Phillips, AN Moroni, M
Citation: G. Rezza et al., Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection, J ACQ IMM D, 25(1), 2000, pp. 56-62
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients
Authors: Monforte, AD Lepri, AC Rezza, G Pezzotti, P Antinori, A Phillips, AN Angarano, G Colangeli, V De Luca, A Ippolito, G Caggese, L Soscia, F Filice, G Gritti, F Narciso, P Tirelli, U Moroni, M
Citation: Ad. Monforte et al., Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients, AIDS, 14(5), 2000, pp. 499-507
Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases
Authors: Giuliani, M Rezza, G Lepri, AC Di Carlo, A Maini, A Crescimbeni, E Palamara, G Prignano, G Caprilli, F
Citation: M. Giuliani et al., Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases, SEX TRA DIS, 27(2), 2000, pp. 87-92
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis
Authors: Babiker, A Darby, S De Angelis, D Kwart, D Porter, K Beral, V Darbyshire, J Day, N Gill, N Coutinho, R Prins, M van Benthem, B Coutinho, R Dabis, F Marimoutou, C Ruiz, I Tusell, J Altisent, C Evatt, B Jaffe, H Kirk, O Pedersen, C Rosenberg, P Goedert, J Biggar, R Melbye, M Brettie, R Downs, A Hamouda, O Touloumi, G Karafoulidou, A Katsarou, O Donfield, S Gomperts, E Hilgartner, M Hoots, K Schoenbaum, E Beral, V Zangerle, R Del Amo, J Pezzotti, P Rezza, G Hutchinson, S Day, N De Angelis, D Gore, S Kingsley, L Schrager, L Rosenberg, P Goedert, J Melnick, S Koblin, B Eskild, A Bruun, J Sannes, M Evans, B Lepri, AC Sabin, C Buchbinder, S Vittinghoff, E Moss, A Osmond, D Winkelstein, W Goldberg, D Boufassa, F Meyer, L Egger, M Francioli, P Rickenbach, M Cooper, D Tindall, B Sharkey, T Vizzard, J Kaldor, J Cunningham, P Vanhems, P Vizzard, J Kaldor, J Learmont, J Farewell, V Berglund, O Mosley, J Operskalski, E van den Berg, M Metzger, D Tobin, D Woody, G Rusnak, J Hendrix, C Garner, R Hawkes, C Renzullo, P Garland, F Darby, S Ewart, D Giangrande, P Lee, C Phillips, A Spooner, R Wilde, J Winter, M Babiker, A Darbyshire, J Evans, B Gill, N Johnson, A Phillips, A Porter, K Lorenzo, JI Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137
Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin a in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels
Authors: Ullum, H Lepri, AC Katzenstein, TL Phillips, AN Skinhoj, P Gerstoft, J Pedersen, BK
Citation: H. Ullum et al., Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin a in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels, SC J IN DIS, 32(4), 2000, pp. 371-376
Resistance profiles in patients with viral rebound on potent antiretroviral therapy
Authors: Lepri, AC Sabin, CA Staszewski, S Hertogs, K Muller, A Rabenau, H Philips, AN Miller, V
Citation: Ac. Lepri et al., Resistance profiles in patients with viral rebound on potent antiretroviral therapy, J INFEC DIS, 181(3), 2000, pp. 1143-1147
Adrenaline-induced mobilization of T cells in HIV-infected patients
Authors: Sondergaard, SR Lepri, AC Ullum, H Wiis, J Hermann, CK Laursen, SB Qvist, J Gerstoft, J Skinhoj, P Pedersen, BK
Citation: Sr. Sondergaard et al., Adrenaline-induced mobilization of T cells in HIV-infected patients, CLIN EXP IM, 119(1), 2000, pp. 115-122
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection
Authors: Sidenius, N Sier, CFM Ullum, H Pedersen, BK Lepri, AC Blasi, F Eugen-Olsen, J
Citation: N. Sidenius et al., Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection, BLOOD, 96(13), 2000, pp. 4091-4095
Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of death
Authors: Aladdin, H Ullum, H Lepri, AC Leffers, H Katzenstein, T Gerstoft, J Gjedde, SB Phillips, AN Skinhoj, P Pedersen, BK
Citation: H. Aladdin et al., Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of death, SC J IMMUN, 50(2), 1999, pp. 223-227
The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996
Authors: Pezzotti, P Serraino, D Rezza, G Dal Maso, L Vaccher, E Lepri, AC Franceschi, S
Citation: P. Pezzotti et al., The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996, INT J EPID, 28(5), 1999, pp. 975-981
Natural immunity and HIV disease progression
Authors: Ullum, H Lepri, AC Aladdin, H Katzenstein, T Victor, J Phillips, AN Gerstoft, J Skinhoj, P Pedersen, BK
Citation: H. Ullum et al., Natural immunity and HIV disease progression, AIDS, 13(5), 1999, pp. 557-563
The influence of nutritional and metabolic status on progression from asymptomatic HIV infection to AIDS-defining diagnosis
Authors: Sharpstone, D Murray, C Ross, H Phelan, M Crane, R Lepri, AC Nelson, M Gazzard, B
Citation: D. Sharpstone et al., The influence of nutritional and metabolic status on progression from asymptomatic HIV infection to AIDS-defining diagnosis, AIDS, 13(10), 1999, pp. 1221-1226
The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997
Authors: Mocroft, A Barry, S Sabin, CA Lepri, AC Kinloch, S Drinkwater, A Lipman, M Youle, M Johnson, MA Phillips, AN
Citation: A. Mocroft et al., The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997, AIDS, 13(10), 1999, pp. 1255-1261
Risk of new AIDS diseases in people on triple therapy
Authors: Miller, V Staszewski, S Nisius, G Lepri, AC Sabin, C Phillips, AN
Citation: V. Miller et al., Risk of new AIDS diseases in people on triple therapy, LANCET, 353(9151), 1999, pp. 463-463
CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus load
Authors: Miller, V Staszewski, S Sabin, C Carlebach, A Rottmann, C Weidmann, E Rabenau, H Hill, A Lepri, AC Phillips, AN
Citation: V. Miller et al., CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus load, J INFEC DIS, 180(2), 1999, pp. 530-533
Risultati: 1-19 |